Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2026-03-19 @ 9:26 PM
Study NCT ID:
NCT04696666
Status:
UNKNOWN
Last Update Posted:
2021-01-06
First Post:
2021-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis
Sponsor:
LIDDE Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLIN-INST01F
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None